Clinical Trials for Prinicipal Investigator: Samuel Ejadi

2 Open Trials. Phone:(877.827.8839)
Protocol No. Title Status
NRG-HN001 Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA) Open
UCI-16-72 A Randomized Double-Blind Phase 3 Study Of Avelumab In Combination With Standard Of Care Chemoradiotherapy (Cisplatin Plus Definitive Radiation Therapy) Versus Standard Of Care Chemoradiotherapy In The Front-Line Treatment Of Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck Open